跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENGERIX-B - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ENGERIX-B
Authorized
STANDARD
ENGERIX-B
GlaxoSmithKline Inc
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
72183596e8d28e4b
Company
GlaxoSmithKline Inc
Type
Standard
Approval Details
Approval Id
72183596e8d28e4b
Drug Approval Canada Name
ENGERIX-B
Product Name
ENGERIX-B
Status
Marketed
Status Date
2019-11-15
Original Market Date
2019-11-15
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intramuscular
Schedule
Schedule D
Ahfs
80:12.00
Atc Original
J07BC01 HEPATITIS B, PURIFIED ANTIGEN
Aig Number
0119570002
Company Name
GlaxoSmithKline Inc
Company Address
800 100 Milverton Drive Mississauga Ontario Canada L5R 4H1
Company Detail Path
/organization/glaxosmithkline-inc
Company Information
Pharmaceutical Company Name
GlaxoSmithKline Inc
Country Name
Canada
Province Name
Ontario
City Name
mississauga,ontario,country_ca
Address
800-100 Milverton Dr
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
72183596e8d28e4b
Type
Standard
Back to Health Canada Approvals